Oct. 23, 2014: N.J. Advances to Third in Nation for Reducing Anti-Psychotic Meds in Nursing Homes
New Jersey has achieved a new level of success in working to reduce the use of antipsychotic medications in nursing homes. Based on the data release for the second quarter of 2014 by the Partnership to Improve Dementia Care in Nursing Homes, New Jersey advanced from fourth to third place in the nation.
The statewide average utilization of these medications with long-stay nursing home residents is 14.2 percent, which represents an almost 21 percent decrease since the second quarter of 2011.
NJHA applauds the efforts of nursing homes throughout the state in this effort to lead the country alongside Hawaii, Michigan and Wisconsin which occupy the first, second and fourth places in overall utilization. Their work continues as they strive to improve even further.
In September the Centers for Medicare and Medicaid Services announced that the Partnership had achieved its initial goal for reducing the use of antipsychotic medications with long term nursing home residents by 15 percent. CMS simultaneously established a new goal of reducing the use of antipsychotic medications in long-stay nursing home residents by 25 percent by the end of 2015, and 30 percent by the end of 2016